Company / Interest Expense per Share
Trevi Therapeutics, Inc. Interest Expense per Share History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2023
5-year range
$0.00 / $0.05
FY2019-FY2023
Trend
-78.1%
vs FY2022
Sector context
#38 of 43
Health Care
What the data says
Trevi Therapeutics, Inc.'s interest expense per share of $0.00 is lower than 88% of companies in the Health Care sector (FY2023). Improved from $0.05 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2023 with a 5-year CAGR of -60.2%.
Improved from $0.05 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -46.1%
- 5-Year CAGR
- -60.2%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 43This company $0.00 Sector average $18.61
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share decreased 78.1% year-over-year.
- Ranks #38 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0.00 | -78.1% |
| FY2022 | $0.02 | -65.8% |
| FY2021 | $0.05 | +108.4% |
| FY2020 | $0.03 | - |
| FY2019 | - | - |
| FY2018 | $0.40 | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026